These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26420594)

  • 1. The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer.
    Schubert T; Todenhöfer T; Mischinger J; Schwentner C; Renninger M; Stenzl A; Gakis G
    World J Urol; 2016 Jun; 34(6):829-34. PubMed ID: 26420594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.
    Grimm T; Buchner A; Schneevoigt B; Kretschmer A; Apfelbeck M; Grabbert M; Jokisch JF; Stief CG; Karl A
    World J Urol; 2016 May; 34(5):703-8. PubMed ID: 26376992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
    Tamalunas A; Buchner A; Kretschmer A; Jokisch F; Schulz G; Eismann L; Stief CG; Grimm T
    Urol Int; 2020; 104(7-8):551-558. PubMed ID: 32114587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
    Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
    BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
    Bruins HM; Arends TJ; Pelkman M; Hulsbergen-van de Kaa CA; van der Heijden AG; Witjes JA
    Clin Genitourin Cancer; 2014 Jun; 12(3):190-5. PubMed ID: 24332508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
    Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A
    World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
    Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer.
    Schubert T; Renninger M; Schmid MA; Hassan FN; Sokolakis I; Fahmy O; Hatzichristodoulou G; Stenzl A; Gakis G
    Urol Oncol; 2020 Jan; 38(1):4.e7-4.e15. PubMed ID: 31537484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.
    Hara T; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Nasu T; Joko K; Baba Y; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Konishi M; Sakano S; Imoto K; Tei Y; Yamaguchi S; Yano S;
    Int J Clin Oncol; 2016 Feb; 21(1):139-47. PubMed ID: 26077140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
    BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.
    Gierth M; Mayr R; Aziz A; Krieger S; Wullich B; Pycha A; Lodde M; Salvadori U; Bründl J; Fritsche HM; Hofstädter F; Pawlik MT; Otto W; May M; Burger M; Denzinger S
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1819-26. PubMed ID: 25832016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
    Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
    Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
    Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
    Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
    Bruins HM; Dorin RP; Rubino B; Miranda G; Cai J; Daneshmand S; Skinner EC
    Eur Urol; 2012 Oct; 62(4):671-6. PubMed ID: 22575915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Klemm J; Shariat SF; Laukhtina E; Rajwa P; Vetterlein MW; Schuettfort VM; von Deimling M; Dahlem R; Fisch M; Rink M
    Clin Genitourin Cancer; 2024 Jun; 22(3):102079. PubMed ID: 38614853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.